Most Recent
The companies that own some of Australia's largest intellectual property boutiques have agreed to a merger that will create a 349 employee-strong firm that's a force to be reckoned with in the market for IP services in Asia Pacific.
A unit of Nestle unit has defeated an opposition to a patent for an internet-connected coffee machine that would allow users to read news and weather while making their morning coffee.
Energy drink giant Monster Energy has dropped its challenge to a ruling allowing alcoholic spirits wholesaler Fernbrew to trade mark the term 'Real Beast' for alcoholic beverages.
A court has delivered a loss for Germany-based B. Braun Melsungen, dismissing its allegations that US-based device manufacturer Becton Dickinson infringed three of its intravenous catheter patents and ruling the patents invalid.
Australian coffee maker Vittoria Food & Beverage has won another challenge to a patent for a coffee pod system filed by a unit of Mondelez International.
Take-Two interactive has won an injunction blocking a Grand Theft Auto gamer from distributing software that allows users to access restricted features of the popular game, a month after reaching a settlement with a gamer in a separate copyright case.
Generic drug maker Dr Reddy's Laboratories has reached a settlement with US-based Millennium Pharmaceuticals, agreeing to be restrained from selling a cheap version of cancer drug Velcade in Australia.
Energy drink giant Monster Energy Company has come up short in two oppositions to trade mark registrations which it claimed would infringe its marks.
US-based Millennium Pharmaceuticals has secured a temporary injunction that bans generic drug maker Juno Pharmaceuticals from importing or selling its cheap version of breakthrough cancer drug Velcade in Australia.
An urgent injunction sought by US-based Millennium Pharmaceuticals to block generic drug maker Dr Reddy's Laboratories from launching a cheap version of the breakthrough cancer drug Velcade has been panned as unnecessary.